NCT04107129

Brief Summary

The purpose of this study is to understand why some women are infertile (unable to conceive a child). The investigators hope to learn if an endometrial biopsy after egg retrieval is feasible for detecting biomarkers for endometriosis and predicting implantation and pregnancy rate after embryo transfer. This study design will provide for the first time, an opportunity to compare endometrial biopsy material from hyperstimulated (gonadotropin treated) subjects after egg retrieval. If successful, it would provide a new protocol for women with unexplained infertility or those with known endometriosis to avoid poor IVF outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
76

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jul 2020

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 17, 2019

Completed
10 days until next milestone

First Posted

Study publicly available on registry

September 27, 2019

Completed
9 months until next milestone

Study Start

First participant enrolled

July 1, 2020

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2023

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2024

Completed
Last Updated

August 14, 2024

Status Verified

July 1, 2023

Enrollment Period

3 years

First QC Date

September 17, 2019

Last Update Submit

August 12, 2024

Conditions

Keywords

InfertilityEndometriosisBLC6SIRT1In Vitro Fertilization (IVF)Embryo Transfer (ET)Frozen Embryo Transfer (FET)Assisted Reproductive Technology (ART)PERFORM

Outcome Measures

Primary Outcomes (1)

  • SIRT1 gene expression in the endometrium

    Endometrial biopsy specimens will be stained for SIRT1 using immunostaining and Hscore assignment.

    2-3 years

Secondary Outcomes (3)

  • BCL6 expression in the endometrium

    2-3 years

  • Number of patients who have a positive pregnancy test (HCG level > 5) 9 days after embryo transfer

    2-3 years

  • Number of embryo transfers that lead to live births

    2-3 years

Study Arms (3)

Known Endometriosis

Known Endometriosis undergoing IVF with PGTA

Procedure: Endometrial BiopsyOther: Euploid embryo transferDiagnostic Test: Blood sample

Unexplained Infertility

Unexplained Infertility undergoing IVF with PGTA

Procedure: Endometrial BiopsyOther: Euploid embryo transferDiagnostic Test: Blood sample

Low Risk Controls

Low Risk Controls undergoing IVF with PGTA

Procedure: Endometrial BiopsyOther: Euploid embryo transferDiagnostic Test: Blood sample

Interventions

An endometrial biopsy is the removal of a small piece of tissue from the endometrium, which is the lining of the uterus. Endometrial tissue will be tested for BCL6 and SIRT1 Biomarkers

Known EndometriosisLow Risk ControlsUnexplained Infertility

Patients undergoing IVF and Preimplantation genetic testing will undergo delayed euploid frozen embryo transfer per clinical protocol and standard of care.

Known EndometriosisLow Risk ControlsUnexplained Infertility
Blood sampleDIAGNOSTIC_TEST

Estradiol and Progesterone levels in the blood will be checked

Known EndometriosisLow Risk ControlsUnexplained Infertility

Eligibility Criteria

Age18 Years - 42 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsAdult females of reproductive age.
Healthy VolunteersNo
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

These criteria are meant to define two populations of women (high and low risk for endometriosis) and not include confounding diagnoses including PCOS, autoimmune conditions and endocrine disorders such as hypothyroidism and hyperprolactinemia.

You may qualify if:

  • Age - 18 to 42
  • AMH ≥ 1
  • Planning to undergo IVF with delayed embryo transfer
  • Must have blastocyst(s) by day 6 that were biopsied for PGT-A
  • BMI 18-35

You may not qualify if:

  • Uterine fibroids \> 4 cm in size
  • Polycystic ovary syndrome (PCOS) according with the Rotterdam criteria.
  • Ovarian failure and subjects receiving donor oocytes/embryos
  • Anti-cardiolipid and/or lupus anti-coagulant abnormalities by history
  • Diabetes mellitus (Type I or Type II)
  • Untreated hypothyroidism
  • Hyperprolactinemia
  • Uncorrected uterine anomaly

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Stanford Fertility and Reproductive Health

Sunnyvale, California, 94087, United States

Location

Related Publications (18)

  • Budwit-Novotny DA, McCarty KS, Cox EB, Soper JT, Mutch DG, Creasman WT, Flowers JL, McCarty KS Jr. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res. 1986 Oct;46(10):5419-25.

    PMID: 3756890BACKGROUND
  • Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I, Brodszky V, Canis M, Colombo GL, DeLeire T, Falcone T, Graham B, Halis G, Horne A, Kanj O, Kjer JJ, Kristensen J, Lebovic D, Mueller M, Vigano P, Wullschleger M, D'Hooghe T. The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod. 2012 May;27(5):1292-9. doi: 10.1093/humrep/des073. Epub 2012 Mar 14.

    PMID: 22422778BACKGROUND
  • Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012 Sep;98(3):511-9. doi: 10.1016/j.fertnstert.2012.06.029. Epub 2012 Jul 20.

    PMID: 22819144BACKGROUND
  • Endometriosis exerts "profound" economic burden in the US. (2007). PharmacoEconomics & Outcomes News. https://doi.org/10.2165/00151234-200705230-00025

    BACKGROUND
  • Evans-Hoeker E, Lessey BA, Jeong JW, Savaris RF, Palomino WA, Yuan L, Schammel DP, Young SL. Endometrial BCL6 Overexpression in Eutopic Endometrium of Women With Endometriosis. Reprod Sci. 2016 Sep;23(9):1234-41. doi: 10.1177/1933719116649711. Epub 2016 May 24.

    PMID: 27222232BACKGROUND
  • Fox C, Morin S, Jeong JW, Scott RT Jr, Lessey BA. Local and systemic factors and implantation: what is the evidence? Fertil Steril. 2016 Apr;105(4):873-84. doi: 10.1016/j.fertnstert.2016.02.018. Epub 2016 Mar 3.

    PMID: 26945096BACKGROUND
  • Lensen S, Osavlyuk D, Armstrong S, Stadelmann C, Hennes A, Napier E, Wilkinson J, Sadler L, Gupta D, Strandell A, Bergh C, Vigneswaran K, Teh WT, Hamoda H, Webber L, Wakeman SA, Searle L, Bhide P, McDowell S, Peeraer K, Khalaf Y, Farquhar C. A Randomized Trial of Endometrial Scratching before In Vitro Fertilization. N Engl J Med. 2019 Jan 24;380(4):325-334. doi: 10.1056/NEJMoa1808737.

    PMID: 30673547BACKGROUND
  • Lessey BA, Metzger DA, Haney AF, McCarty KS Jr. Immunohistochemical analysis of estrogen and progesterone receptors in endometriosis: comparison with normal endometrium during the menstrual cycle and the effect of medical therapy. Fertil Steril. 1989 Mar;51(3):409-15. doi: 10.1016/s0015-0282(16)60545-9.

    PMID: 2646155BACKGROUND
  • Lessey BA, Palomino WA, Apparao KB, Young SL, Lininger RA. Estrogen receptor-alpha (ER-alpha) and defects in uterine receptivity in women. Reprod Biol Endocrinol. 2006;4 Suppl 1(Suppl 1):S9. doi: 10.1186/1477-7827-4-S1-S9.

    PMID: 17118173BACKGROUND
  • Likes CE, Cooper LJ, Efird J, Forstein DA, Miller PB, Savaris R, Lessey BA. Medical or surgical treatment before embryo transfer improves outcomes in women with abnormal endometrial BCL6 expression. J Assist Reprod Genet. 2019 Mar;36(3):483-490. doi: 10.1007/s10815-018-1388-x. Epub 2019 Jan 4.

    PMID: 30610661BACKGROUND
  • Littman E, Giudice L, Lathi R, Berker B, Milki A, Nezhat C. Role of laparoscopic treatment of endometriosis in patients with failed in vitro fertilization cycles. Fertil Steril. 2005 Dec;84(6):1574-8. doi: 10.1016/j.fertnstert.2005.02.059.

    PMID: 16359945BACKGROUND
  • Meyer WR, Lessey BA, Castelbaum AJ. Hydrosalpinx and altered uterine receptivity. Fertil Steril. 1997 Nov;68(5):944-5. doi: 10.1016/s0015-0282(97)90360-5. No abstract available.

    PMID: 9389833BACKGROUND
  • Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998 Apr 30;17(8):857-72. doi: 10.1002/(sici)1097-0258(19980430)17:83.0.co;2-e.

    PMID: 9595616BACKGROUND
  • Revised American Society for Reproductive Medicine classification of endometriosis: 1996. Fertil Steril. 1997 May;67(5):817-21. doi: 10.1016/s0015-0282(97)81391-x. No abstract available.

    PMID: 9130884BACKGROUND
  • Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3(6):1101-8. doi: 10.1038/nprot.2008.73.

    PMID: 18546601BACKGROUND
  • Talbi S, Hamilton AE, Vo KC, Tulac S, Overgaard MT, Dosiou C, Le Shay N, Nezhat CN, Kempson R, Lessey BA, Nayak NR, Giudice LC. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology. 2006 Mar;147(3):1097-121. doi: 10.1210/en.2005-1076. Epub 2005 Nov 23.

    PMID: 16306079BACKGROUND
  • Vitagliano A, Di Spiezio Sardo A, Saccone G, Valenti G, Sapia F, Kamath MS, Blaganje M, Andrisani A, Ambrosini G. Endometrial scratch injury for women with one or more previous failed embryo transfers: a systematic review and meta-analysis of randomized controlled trials. Fertil Steril. 2018 Sep;110(4):687-702.e2. doi: 10.1016/j.fertnstert.2018.04.040.

    PMID: 30196966BACKGROUND
  • Yoo JY, Kim TH, Fazleabas AT, Palomino WA, Ahn SH, Tayade C, Schammel DP, Young SL, Jeong JW, Lessey BA. KRAS Activation and over-expression of SIRT1/BCL6 Contributes to the Pathogenesis of Endometriosis and Progesterone Resistance. Sci Rep. 2017 Jul 28;7(1):6765. doi: 10.1038/s41598-017-04577-w.

    PMID: 28754906BACKGROUND

Biospecimen

Retention: SAMPLES WITHOUT DNA

Endometrial biopsy will be collected. Urine, saliva, and blood samples will also be collected for future studies

MeSH Terms

Conditions

Infertility, FemaleEndometriosisInfertility

Interventions

Blood Specimen Collection

Condition Hierarchy (Ancestors)

Genital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Diseases

Intervention Hierarchy (Ancestors)

Specimen HandlingClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisPuncturesSurgical Procedures, OperativeInvestigative Techniques

Study Officials

  • Ruth B Lathi, MD

    Stanford University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Obstetrics and Gynecology

Study Record Dates

First Submitted

September 17, 2019

First Posted

September 27, 2019

Study Start

July 1, 2020

Primary Completion

July 1, 2023

Study Completion

July 30, 2024

Last Updated

August 14, 2024

Record last verified: 2023-07

Data Sharing

IPD Sharing
Will not share

No PHI will be shared with collaborators. Collaborators will only have access to aggregate data by study group

Locations